More than 99% of bankrupt drugmaker Purdue Pharma's creditors voted to accept a $7.4 billion settlement of legal claims related to the company's sales of addictive opioid medication, the company said ...

A rebound in pharmaceutical-research investment would be a boost to Danaher, which provides technologies and tools for drug development. The Washington, D.C., company reiterated its full-year profit ...

Danaher recorded higher third-quarter sales and profit on the back of momentum in its bioprocessing business and ...

Two advisers to U.S. Health and Human Services Secretary Robert F. Kennedy Jr. sat on a stage in California this spring, ...

Powerful anti-vaccine advocates and people selling potentially harmful goods such as raw milk are profiting from the push to ...

Danaher recorded higher third-quarter sales and profit on the back of momentum in its bioprocessing business and better-than-expected sales in its respiratory market. The life sciences and diagnostics ...

Japan has for the first time approved over-the-counter sales of an emergency contraceptive pill, its manufacturer says, allowing women in the country to take the medication without prescription.

Xeris Biopharma’s strong Q2 FY2025 results, driven by Recorlev’s growth. Learn how shifting product mix boosts XERS stock's ...

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is one of the 11 Dirt Cheap Stocks to Buy According to Analysts.

Pfizer ( PFE) is number one and the leader in my list of "top 3 Big Pharma stocks." Over the last three quarters I have seen ...

(Reuters) -Several pharmaceutical companies have said they will sell drugs direct to patients in the U.S. and offered ...